arrow
E

Emmanuel S. Antonarakis

Masonic Cancer Center
H指数:14
被引数:592

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Transferrin Receptor Overexpression in Solid Tumors Is Associated with Inflamed Microenvironments and Upregulated Immune Checkpoints, with Implications for Immunotherapy Sensitivity

实体瘤中转铁蛋白受体过表达与炎症微环境和上调的免疫检查点相关,对免疫治疗敏感性具有影响

Cancers
IF4.4
2026-04-290
OA
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study

恩扎卢替尼在转移性激素敏感前列腺癌中的应用:国际、多中心真实世界ARON-3研究的结果

2026-01-080
OAAI
Molecular alteration profiles characterize intraductal carcinoma of the prostate

分子改变特征可表征导管内前列腺癌

Cancer
IF5.1
2026-01-010
PRE
Author Correction: CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer

作者更正:CREB5 促进致瘤性并上调可成药性细胞表面模态在基底样乳腺癌中

2025-11-200
OAAI
HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer

HLA class I expression塑造前列腺癌的肿瘤免疫微环境并影响其预后

2025-10-250
OA
Correction: Natural killer cell infiltration in prostate cancers predict improved patient outcomes

更正:自然杀伤细胞浸润在前列腺癌中预测患者预后改善

2025-08-120
OAAI
Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer

循环肿瘤DNA中的致病基因组改变可预测转移性去势抵抗性前列腺癌患者的总生存期

2025-08-060
PREAI
Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair–deficient Metastatic Castration-resistant Prostate Cancer

PD-(L)1免疫疗法在DNA错配修复缺陷型转移性去势抵抗性前列腺癌患者中的疗效

2025-07-120
OAAI
Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo-Controlled, Biomarker-Enriched Trial in Patients With the SOD2 Ala/Ala Variant

蛇皮葡萄提取物在生物化学复发性前列腺癌中的应用:一项针对携带SOD2 Ala/Ala变异患者的随机、安慰剂对照、生物标志物富集试验

2025-05-050
PRE
T-cell Engagers in Prostate Cancer

T细胞结合剂在前列腺癌中的应用

2025-05-011
PRE
Androgen production, uptake, and conversion (APUC) genes define prostate cancer patients with distinct clinical outcomes

雄激素产生,摄取和转化 (APUC) 基因定义了具有不同临床结果的前列腺癌患者

2024-10-221
OA